A cutting-edge biotech was running a program with three active, concurrent, pain studies across 25 sites and 218 patients, with interim database locks scheduled during the summer of 2020 and final database lock deadlines looming close behind. The COVID-19 pandemic put that all on the line. The sponsor relied on our team’s operational expertise and site relationships to find creative solutions around site availability, patient retention, and remote monitoring of the data that would ensure patient safety, data quality, and allow study progression to continue without delay.

Download our case study to see how we were able to successfully adjust protocols by implementing site-specific solutions and operational efficiencies while maintaining the integrity and quality of primary endpoints. This case study outlines the implementation of the following initiatives:

• Visit Window Extensions
• Telemedicine Visits
• Contract Updates
• Remote Monitoring Visits
• EDC Migration